XML 22 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Equity (Tables)
 3 Months Ended
Mar. 31, 2020
Stockholders' Equity Note [Abstract]  
Schedule of Net Income Attributable to Common Stockholders and Transfers (to) from Noncontrolling Interests
The table below presents the effect on our equity from net income attributable to common stockholders and changes in our ownership interest in our Operating Partnership:

 
Three Months Ended March 31,
(In thousands)
2020
 
2019
 
 
 
 
Net income attributable to common stockholders
$
26,923

 
$
28,701

 
 
 
 
Transfers from noncontrolling interests:
 
 
 
Exchange of OP Units with noncontrolling interests
90

 
363

Repurchase of OP Units from noncontrolling interests
(4
)
 
(291
)
Net transfers from noncontrolling interests
86

 
72

 
 
 
 
Change from net income attributable to common stockholders and transfers from noncontrolling interests
$
27,009

 
$
28,773
Schedule of Accumulated Other Comprehensive Income (Loss)
The table below presents a reconciliation of our AOCI, which consists solely of adjustments related to derivatives designated as cash flow hedges:

 
Three Months Ended March 31,
(In thousands)
2020
 
2019
 
 
 
 
Beginning balance
$
(17,462
)
 
$
53,944

Consolidated derivatives:
 
 
 
Other comprehensive loss before reclassifications
(206,597
)
 
(21,563
)
Reclassification of gains from AOCI to Interest Expense
(420
)
 
(8,724
)
Unconsolidated Funds' derivatives (our share)(2):
 
 
 
Other comprehensive loss before reclassifications
(370
)
 
(2,405
)
Reclassification of gains from AOCI to Income from unconsolidated Funds
(72
)
 
(616
)
Net current period OCI
(207,459
)
 
(33,308
)
OCI attributable to noncontrolling interests
59,049

 
10,307

OCI attributable to common stockholders
(148,410
)
 
(23,001
)
 
 
 
 
Ending balance
$
(165,872
)
 
$
30,943

___________________________________________________
(1)
See Note 9 for the details of our derivatives and Note 12 for our derivative fair value disclosures.
(2)
We calculate our share by multiplying the total amount for each Fund by our equity interest in the respective Fund.
Schedule of Stock-based Compensation Expense The table below presents our stock-based compensation expense:

 
Three Months Ended March 31,
(In thousands)
2020
 
2019
 
 
 
 
Stock-based compensation expense, net
$
2,941

 
$
2,630

Capitalized stock-based compensation
$
859

 
$
670